Skip to main content

ORIGINAL RESEARCH article

Front. Trop. Dis.

Sec. Antimicrobial Resistance

Volume 6 - 2025 | doi: 10.3389/fitd.2025.1499098

This article is part of the Research Topic Antimicrobial Resistance Response Perspectives in Africa View all 4 articles

Bacterial Profile and Antimicrobial Susceptibility Patterns among Patients Clinically Suspected of Bacterial Conjunctivitis at the Ophthalmologic Clinic of Jimma Medical Center, Southwest Ethiopia

Provisionally accepted
Mekonnen Damessa Mamo Mekonnen Damessa Mamo 1*Eyosias Teklemariam Eyosias Teklemariam 2Mamo Nigatu Mamo Nigatu 3Bikila Alemu Bikila Alemu 1Kumale Tolesa Kumale Tolesa 1Daba Abdissa Daba Abdissa 4Korinan Fanta Korinan Fanta 1
  • 1 Institute of Health, Jimma University, Jimma, Ethiopia
  • 2 Department of Nursing, College of Health Sciences, Mattu University, Mattu, Ethiopia
  • 3 Department of Epidemiology, Faculty of Public Health, Institute of Health, Jimma University, Jimma, Oromia Region, Ethiopia
  • 4 Department of Biomedical sciences, Jimma University, Jimma, Oromia Region, Ethiopia

The final, formatted version of the article will be published soon.

    Background: Bacterial conjunctivitis is a significant cause of ocular morbidity globally, with increasing antimicrobial resistance posing a challenge to effective treatment. In Ethiopia, data on bacterial profiles and antimicrobial susceptibility patterns in conjunctivitis are limited. This study aimed to assess the bacterial profile and antimicrobial susceptibility patterns among patients clinically suspected of bacterial conjunctivitis at Jimma Medical Center, Ethiopia.A facility-based cross-sectional study was conducted from January to June 2022.Conjunctival swabs were collected, and bacterial identification and antimicrobial susceptibility testing were performed using standard microbiological methods.Results: Among 190 patients, 160 (84.2%) had culture-confirmed bacterial conjunctivitis.Gram-positive bacteria, particularly Coagulase-negative staphylococci (35.6%) and Staphylococcus aureus (21.9%), were predominant. High resistance rates were observed for penicillin, ampicillin, and tetracycline, while meropenem and piperacillin/tazobactam showed better efficacy. Multidrug resistance was detected in 77.5% of isolates.Conclusions: Coagulase-negative staphylococcus and Staphylococcus aureus were the two most predominant bacterial isolates with high resistance to frequently used antibiotics such as penicillin, ampicillin, and tetracycline. Therefore, empirical treatment of bacterial conjunctivitis should be supported by antimicrobial susceptibility tests in the study area.

    Keywords: antimicrobial resistance, Antibiotic susceptibility pattern, Conjunctivitis, Ocular Infections, Red eye

    Received: 20 Sep 2024; Accepted: 28 Feb 2025.

    Copyright: © 2025 Mamo, Teklemariam, Nigatu, Alemu, Tolesa, Abdissa and Fanta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mekonnen Damessa Mamo, Institute of Health, Jimma University, Jimma, Ethiopia

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more